475 related articles for article (PubMed ID: 27206986)
1. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
2. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
[TBL] [Abstract][Full Text] [Related]
3. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
4. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
Front Immunol; 2021; 12():681941. PubMed ID: 34295332
[TBL] [Abstract][Full Text] [Related]
5. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren's syndrome.
Leehan KM; Pezant NP; Rasmussen A; Grundahl K; Moore JS; Radfar L; Lewis DM; Stone DU; Lessard CJ; Rhodus NL; Segal BM; Kaufman CE; Scofield RH; Sivils KL; Montgomery C; Farris AD
Autoimmunity; 2017 Dec; 50(8):451-457. PubMed ID: 28988489
[TBL] [Abstract][Full Text] [Related]
6. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
10. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
11. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
Ciccia F; Alessandro R; Rodolico V; Guggino G; Raimondo S; Guarnotta C; Giardina A; Sireci G; Campisi G; De Leo G; Triolo G
Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
[TBL] [Abstract][Full Text] [Related]
12. CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases.
Ohlsson M; Szodoray P; Loro LL; Johannessen AC; Jonsson R
Scand J Immunol; 2002 Dec; 56(6):561-71. PubMed ID: 12472667
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
14. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.
Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
16. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
[TBL] [Abstract][Full Text] [Related]
17. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
Kang KY; Kim HO; Kwok SK; Ju JH; Park KS; Sun DI; Jhun JY; Oh HJ; Park SH; Kim HY
Arthritis Res Ther; 2011; 13(5):R179. PubMed ID: 22030011
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome.
Kurimoto C; Kawano S; Tsuji G; Hatachi S; Jikimoto T; Sugiyama D; Kasagi S; Komori T; Nakamura H; Yodoi J; Kumagai S
J Rheumatol; 2007 Oct; 34(10):2035-43. PubMed ID: 17896802
[TBL] [Abstract][Full Text] [Related]
19. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.
Daniels TE; Cox D; Shiboski CH; Schiødt M; Wu A; Lanfranchi H; Umehara H; Zhao Y; Challacombe S; Lam MY; De Souza Y; Schiødt J; Holm H; Bisio PA; Gandolfo MS; Sawaki T; Li M; Zhang W; Varghese-Jacob B; Ibsen P; Keszler A; Kurose N; Nojima T; Odell E; Criswell LA; Jordan R; Greenspan JS;
Arthritis Rheum; 2011 Jul; 63(7):2021-30. PubMed ID: 21480190
[TBL] [Abstract][Full Text] [Related]
20. Histopathological environment besides the focus score in Sjögren's syndrome.
Llamas-Gutierrez FJ; Reyes E; Martínez B; Hernández-Molina G
Int J Rheum Dis; 2014 Nov; 17(8):898-903. PubMed ID: 25293642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
